RCT to evaluate effect of simillimum in modifying anger and thereby reducing hypertension

A RANDOMISED CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF HOMOEOPATHIC SIMILIMUM IN MODIFYING ANGER, STATE TRAIT AND EXPRESSION IN PATIENTS WITH ESSENTIAL HYPERTENSION AND THEREBY REDUCING THEIR BLOOD PRESSURE- A Technology integrated innovative Homeopathic approach to control Hypertension. - TiÂ²HÂ²

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048479

Enrollment

300

Registered

2022-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Indicated homeopathic medicine: Homoeopathic casetaking will be done and individualisedhomoeopathic remedy will be prescribed depending on the totality of symptoms. It will be administe

Eligibility

Inclusion criteria

Inclusion criteria: cases of essential hypertension

Exclusion criteria

Exclusion criteria: 1. Cases of secondary hypertension 2. Pregnant and lactating women 3. Cases of acute psychiatric illnesses

Design outcomes

Primary

Measure	Time frame
1. Reduction in anger 2. Reduction in systolic BP 3. Reduction in diastolic BP 4. Prevention of end-organ damage 5.. Reduction in end-organ damageTimepoint: one year	—

Secondary

Measure	Time frame
Reduction in severity of symptoms of associated illnessesTimepoint: one year	—

Countries

India

Contacts

Public ContactDrLeena S Bagadia

Sonajirao Kshirsagar Homoeopathic Medical College, Beed

leenabagadia@gmail.com9870098982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026